8 a.m. – 5:30 p.m.

�e Socony-Mobil BuildingWells Fargo Auditorium150 East 42nd Street | NYC

At the completion of the Symposium, learners will be able to:

• Identify indications and contraindications for LAA occlusion

• Describe indications and contraindications for PFO closure

• Discuss the role of the heart brain team in clinical decision-making for stroke prevention

• Classify and identify treatment strategies for minor and major bleeding with the use of apixaban, dabigatran,

edoxaban and rivaroxaban

• Select and interpret appropriate coagulation tests to manage the care of a patients experiencing a major bleed

• Identify appropriate sources for clinical practice guidelines for managing DOAC-associated bleeding

• Describe the diversity of diet types challenging our patients

• Explain policy imperatives in preventing diabetes, CVD and obesity

• List examples of high phenolic foods and their associated disease bene�ts

• Summarize the �ndings from CV outcomes studies of PCSK9i

• Identify speci�c patient populations that would bene�t from LDL-C lowering utilizing PCSK9i therapies

• Apply the guidance from the latest clinical recommendations for the use of PCSK9i

• Implement strategies to overcome common obstacles and potential solutions to increase patient access to PCSK9i

• Discuss how advanced cardiac imaging can be used for the diagnosis of in�ltrative cardiomyopathies and to

monitor response to medical therapy

• Summarize treatment options, including novel medical therapies and advanced heart failure surgical therapies,

that are available for patients with in�ltrative cardiomyopathy

PROGRAM OBJECTIVES

THE

TWELFTH ANNUAL

Presented by

of the

in association with

Friday, June 7, 2019

PROGRAM DESCRIPTION AND TARGET AUDIENCE

NYCS DISCLOSURE STATEMENT

�e New York Cardiological Society, Inc. relies upon invited faculty participants in its CME programs to provide educational information that is objective and free of bias. In this spirit, and in accordance with the guidelines of the program sponsor, faculty participants are expected to indicate any commercial relationship of interest. Any discussion of investigational or unlabeled uses of a product will be identi�ed.

GOALS STATEMENT

JOINT ACCREDITATION STATEMENT In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and �e New York Cardiological Society. �e Postgrad-uate Institute for Medicine is jointly accredited by Accredita-tion Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CONTINUING MEDICAL EDUCATION �e Postgraduate Institute for Medicine designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commen-surate with the extent of their participation in the activity.

555

8th

Ave

nue,

Suite

190

2N

ew Y

ork,

NY

100

18

CONFERENCE VENUE

Demand for cardiac care continues to increase due to the aging population, the obesity epidemic and the persistent incidence of cardiovascular disease in the population. At present, CVD is still by far the most common diagnosis among all hospital discharges in the United States. Chronic disease will become an important component of cardiology practice and care teams, consisting of nurses, nurse practitioners, physician assistants, pharmacists andphysicians, and will provide the most e�cient means of providing ongoing care and long-term follow-up andmanagement of cardiovascular patients. �e 12th Annual Cardiovascular Team Symposium is a unique academic event designed to enhance current knowledge about the etiology, prevention, intervention and management of cardiovascular disease. Presentations will provide cardiovascular team members with evidence-based approaches to the treatment and care of the cardiac patient and information regarding current and cutting-edge technologies. �is activity is designed to meet the educational needs of physicians, physician assistants, nurse practitioners and other healthcare professionals, including nurses, sonographers and all other members of the cardiovascular team.

3RD Annual NYACCSUMMER SOIRÉE

�e overall goal of this activity is to improve patient care by increasing learner knowledge and competence.

CARDIO-VASCULARTEAM SYMPOSIUM

Event sta� will be glad to assist you with any special needs (i.e., physical, dietary, etc). Contact us prior to the live event at (212) 686-0228.

�is activity is jontly provided by Postgraduate Institute for Medicine and �e New York Cardiology Society

NY-

AC

C.o

rg/2

019-

CV

T |

ask

@ny

-acc

.org

555

8th

Ave

., Su

ite 1

902,

New

Yor

k, N

Y

Whe

re to

Reg

ister

:

(212

) 686

-022

8

�e “Mastering the Art of Prior Authorization to Improve Patient Access to PCSK9 Inhibitors” session and associated workshop are Jointly Provided by �e New York Cardiological Society and Integrity CE. �e “Mastering the Art of Prior Authorization to Improve Patient Access to PCSK9 Inhibitors” session and associated workshop are supported by an independent educational funding donation provided by Amgen. Credit for these activities will be provided separately.

�e LCL Bar & Kitchen212 East 42nd Street | NYC

SOIRÉE VENUE�e New York Cardiological Society and New York State Chapter of the American

College of Cardiology thank New York Cardiac Center for its continued educational support.

&Soi

rée

LC

L B

AR

& K

ITC

HE

N

AT

TH

E W

ES

TIN

21

2 E

AS

T 4

2N

D S

T |

NY

C

5:3

0-7

PM

CO

ME

NE

TW

OR

K W

ITH

YO

UR

C

V C

OLL

EA

GU

ES

AF

TE

R T

HE

S

YM

PO

SIU

M A

T T

HE

20

19

...

SUMMER

HO

ST

ED

BY

EAR

LY-B

IRD

(EB)

/ R

EGU

LAR

REG

IST

RAT

ION

:A

CC

Mem

ber/

Cha

pter

Mem

ber -

Fre

e (EB

) / $2

5N

on-C

hapt

er-M

embe

r CV

T A

ttend

ee -

$25 (

EB) /

$45

No-

AC

C-A

�lia

tion

CV

T A

ttend

ee -

$25

(EB)

/ $4

5A

CC

-Mem

ber P

hysic

ian

- $45

(EB)

/ $6

5N

on-M

embe

r Phy

sicia

n - $

65 (E

B) /

$85

Em

eritu

s-M

embe

r Phy

sicia

ns -

Free

(EB)

/ $2

5 Fe

llows

in T

rain

ing,

Res

iden

ts, S

tude

nts -

Fre

e (EB

) / $2

5O

ther

(non

-phy

sicia

n, n

on-C

VT

) - $

75 (E

B) /

$95

Walk

-in ra

te (a

fter M

ay 3

1, 20

19) -

$10

0

CAR

DIO

-VA

SCU

LAR

TEA

M

SYM

POSI

UM

TH

E T

WEL

FTH

AN

NU

AL

HO

ST

ED

BY

Norma M. Keller, MD, FACCChief of Cardiology, Bellevue HospitalDownstate Governor, NYACCPresident, NYCS

Joe Oliveri, RCDS, MSLead Cardiac SonogrpaherHighland Hospital

Kena Patel, MS, PA-CNewYork-Presbyterian HospitalDownstate CVT Liaison, NYACC

Mary Patterson, CAE, MA, MSAExecutive DirectorNew York Cardiological Society

Lori Reyes, ANP-BCPulmonary Hypertension & Advanced Heart Failure Program�e Mount Sinai Medical Center

Courtney Shores, MHS, PA-C Highland HospitalUpstate CVT Liaison, NYACC

10:35 a.m. Q & A

10:45 a.m. ATRIAL FIBRILLATION: UPDATE IN MANAGEMENT

Ramesh Daggubati, MD

5:20 p.m.Q & A

3:45 p.m. BREAK & EXHIBITS

4:15 p.m. ‘MISS’PERCEPTIONS & DISPARITIES OF CARE IN WOMEN WITH HEART DISEASE: HOW FAR HAVE WE COME?

Himabindu Vidula, MD, MS, FACC

3:10 p.m. EXPOSING THE INFILTRATOR: THE DIAGNOSIS & MANAGEMENT OF INFILTRATIVE CARDIOMYOPATHIES

4:45 p.m. Q & A

Norma M. Keller, MD, FACC

3:40 p.m. Q & A

Ibrahim Almasry, MDCardiologistStony Brook Medicine

Ramesh Daggubati, MD Associate Chief of CardiologyNYU Winthrop

Norma M. Keller, MD, FACCChief of Cardiology, Bellevue HospitalDownstate Governor, NYACCPresident, NYCS

4:50 p.m. THE TRACEY SHANNON LECTURE

Speaker TBA

Ibrahim Almasry, MD

Ellen Mandel, DMH, MPA, PA-CProfessor, Department of PA StudiesPace University

Srihari S. Naidu, MDDirectorWestchester Medical Center’s Hypertrophic Cardiomyopathy Center

Sarah A. Spinler, PharmD, AACCProfessor EmeritusPhiladelphia College of Pharmacy

James A. Underberg, MD, PLLCDirectorBellevue Hospital Lipid Clinic

Himabindu Vidula, MD, FACCAdvanced Heart Failure & Transplant CardiologistUniversity of Rochester Medical Ctr.

Norma M. Keller, MD, FACCPresident

J. Chad Teeters, MD, FACCPresident-Elect

Jay J. Dubowsky, MD, FACCSecretary-Treasurer

Executive BoardJohn Bisognano, MD, FACCLeway Chen, MD, MPH, FACCSmadar Kort, MD, FACCJoseph Lauterstein, MD, FACCWilliam E. Lawson, MD, FACCTimothy J. Malins, MD, FACCAndrew Van Tosh, MD, FACC

Ex-O�cio Board MembersJe�rey S. Borer, MD, PhD, FACCPeter F. Cohn, MD, FACCPaul Klig�eld, MD, FACCH. C. Odabashian Jr., MD, FACCMary L. Patterson, CAE, MA, MSADaniel J. Williford, MD, PhD, FACC

Executive Director Mary Patterson, MA, MSA

J. Chad Teeters, MD, FACCPresident

Norma M. Keller, MD, FACCPresident-Elect

Jay J. Dubowsky, MD, FACCSecretary-Treasurer

CouncilorsMarc Baker, MD, FACCRichard Charney, MD, FACCJay J. Dubowsky, MD, FACCDmitriy Feldman, MD, FACCT. Sloane Guy, MD, FACCAyman Iskander, MD, FACCJennifer Lang, MD, FACCLloyd D. Lense, MD, FACCJohn N. Makaryus, MD, FACCLaura Ford-Mukkamala, DO, FACCJulio Panza, MD, FACCJason D. Pacos, MD, FACCFarbod Raiszadeh, MD, PhD, FACCRobert Roswell, MD, FACCJoshua Schulman-Marcus, MD, FACCMandeep S. Sidhu, MD, FACCHimabindu Vidula, MD, FACC

CVT RepresentativesCourtney Shores, MHS, PA-C, UpstateKena Patel, MS, PA-C, Downstate

FIT RepresentativesMoustafa Elsheshtawy, MD, DownstateJacqueline H. Morris, DO, Upstate

Delegate to MSSNYJoseph Tartaglia, MD, FACC

MSSNY Interspecialty Committee RepresentativeMichael J. Wolk, MD, MACC

Richard J. GlazerPresident

Michael J. Wolk, MD, MACCExecutive Vice President

David M. CordermanSecretary

Alfred S. GlazierTreasurer

Board of GovernorsMichael Beals, DDSEdward BindelDavid M. CordermanHon. Bertram GelfandDavid Glazer, Esq.Richard J. GlazerAlfred S. GlazierJerome GoldsteinJo�rey PearlmanMichael Rogow, DDSAnne Ronan, Esq.Lisa Troy, MDMichael J. Wolk, MD, MACCRobert Wolk

Ellen Mandel, DMH, MPA, MS, PA-C, RDN, CDE

James Underberg, MD

OPENING REMARKS

REGISTRATION, BREAKFAST & EXHIBITS8:00 a.m.

9 a.m.

8:45 a.m.

Norma M. Keller, MD, FACCDownstate Governor, NYACCPresident, New York Cardiologial Society

PLUGGING HOLES & SEALING APPENDAGES: CAN WE PREVENT STROKE?

Srihari S. Naidu, MD

9:30 a.m. Q & A

9:35 a.m. MANAGING DIRECT ORAL ANTICOAGULANT BLEEDING IN THE ERA OF REVERSAL AGENTS

10:05 a.m. Q & A

Sarah A. Spinler, PharmD, FCCP, FAHA, FASHP, AACC, BCPS-AQ Cardiology

10:20 a.m.

KEYNOTE PRESENTATION: LIFESTYLE INTERVENTIONS10:50 a.m.

BREAK & EXHIBITS

MASTERING THE ART OF PRIOR AUTHORIZATION TO IMPROVE PATIENT ACCESS TO PCSK9 INHIBITORS 11:30 a.m.

11:20 a.m. Q & A

“A New Narrative for Diabetes Management & Metabolic Health”

(Workshop to Follow)

LUNCH, REVIEW OF MORNING TALKS & EXHIBITS12:30 p.m.

Q & A

INDICATIONS AND CONTRAINDICATIONS OF PFO CLOSURE2:00 p.m.

2:35 p.m.

2:35 p.m. WHY ATRIAL FIBRILLATION ABLATION IS FIRST-LINE TREATMENT IN 2019

Q & A3:05 p.m.

5:30 p.m. SUMMER SOIRÉE BEGINS AT LCL BAR & KITCHEN

Catarina StrømbergProgram AssociateNew York Cardiological Society

Chad Teeters, MD, RPVI, FACCChief of Cardiology, Highland HospitalUpstate Governor, NYACCPresident-Elect, NYCS

Michele L. Xikis, ANP-BCElectrophysiologyStony Brook Medicine

AMERICAN BOARD OF INTERNAL MEDICINE’S (ABIM) MAINTENANCE OF CERTIFICATION (MOC)

�e Postgraduate Institute for Medicine designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only

the credit commensurate with the extent of their participation in the activity.

5:20 p.m.